Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2015
16th World Conference on Lung Cancer
Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado
Presentation Date(s):- September 6 - 9, 2015
- Total Presentations: 2499
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
-
+
P1.04 - Poster Session/ Biology, Pathology, and Molecular Testing
- Type: Poster
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 116
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.04-074 - ITPKA Expression in Lung and Other Cancers, Regulated via Gene Body Methylation, Functions as an Oncogene
09:30 - 09:30 | Author(s): Y. Wang
- Abstract
Loading... -
+
P1.04-086 - Dopamine D2 Receptor Agonists Inhibit Lung Cancer Progression by Reducing Angiogenesis and Tumor Infiltrating Myeloid Derived Suppressor Cells
09:30 - 09:30 | Author(s): L.H. Hoeppner
- Abstract
Loading...
-
+
MINI 10 - ALK and EGFR
- Type: Mini Oral
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 15
- Moderators:T. Yap
- Coordinates: 9/07/2015, 16:45 - 18:15, Mile High Ballroom 1a-1f
-
+
MINI10.13 - Prediction of Human Pharmacokinetics, Efficacious Dose and BBB Penetration of a Novel EGFR Inhibitor for Treating NSCLC with CNS Metastasis
17:55 - 18:00 | Author(s): K. Chen
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 102
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.01-027 - Responses to Crizotinib in Six Lung Adenocarcinoma Patients of ALK IHC-Positive and FISH-Negative
09:30 - 09:30 | Author(s): D. Ma
- Abstract
Loading...
-
+
P2.04 - Poster Session/ Biology, Pathology, and Molecular Testing
- Type: Poster
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 109
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.04-019 - PD 0332991 Inhibits the Growth of Gefitinib-Resistant Human Lung Cancer Cells in Vitro and in Vivo, When Combined with Gefitinib
09:30 - 09:30 | Author(s): H. Liu
- Abstract
Loading... -
+
P2.04-026 - Second Generation EGFR TKIs Inhibit Tumor Growth in a Chemo-Resistant Squamous Cell Lung Cancer Patient Derived Xenograft Model
09:30 - 09:30 | Author(s): C. Mascaux
- Abstract
Loading...
-
+
ORAL 21 - Biology - Moving Beyond the Oncogene to Oncogene-Modifying Genes
- Type: Oral Session
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 7
- Moderators:A. Katz
- Coordinates: 9/08/2015, 10:45 - 12:15, Mile High Ballroom 4a-4f
-
+
ORAL21.05 - p53/KRAS Mutation Status Does Not Predict Sensitivity to Chemotherapy in NSCLC PDXs
11:28 - 11:39 | Author(s): C. Mascaux
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ORAL 25 - Biology and Other Issues in SCLC
- Type: Oral Session
- Track: Small Cell Lung Cancer
- Presentations: 8
- Moderators:J. Sage
- Coordinates: 9/08/2015, 10:45 - 12:15, 605+607
-
+
ORAL25.05 - Predictive and Prognostic Significance of Myeloid-Derived Suppressor Cells in Patients with Small-Cell Lung Cancer
11:28 - 11:39 | Author(s): Y. Cheng
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MINI 21 - Novel Targets
- Type: Mini Oral
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 13
- Moderators:B.P. Levy
- Coordinates: 9/08/2015, 16:45 - 18:15, Mile High Ballroom 2a-3b
-
+
MINI21.04 - HS3ST3B1 Is a Novel Regulator of TGF-Beta Mediated EMT and Regulated by miR-218 in Lung Cancer
17:00 - 17:05 | Author(s): L. Miao
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MINI 25 - Trials, Radiation and Other
- Type: Mini Oral
- Track: Thymoma, Mesothelioma and Other Thoracic Malignancies
- Presentations: 15
- Moderators:J.M. Clavero
- Coordinates: 9/08/2015, 16:45 - 18:15, 702+704+706
-
+
MINI25.02 - A Clinical Study on Intra-Thoracic Chemotherapy of Recombinant Human Endostatin Combined with Cisplatin for Malignant Pleural Effusion
16:50 - 16:55 | Author(s): X. Hu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 91
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.01-024 - The Effect of Pemetrexed as First Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer with Anaplastic Lymphoma Kinase Gene Rearrangements
09:30 - 09:30 | Author(s): D. Ma
- Abstract
Loading... -
+
P3.01-039 - Patient Characteristics and Treatment Outcome of Advanced Non-Squamous NSCLC with over 6-Month Disease Control from Icotinib
09:30 - 09:30 | Author(s): S. Yang
- Abstract
Loading... -
+
P3.01-052 - Randomized Phase II Individualized Chemotherapy Study Based on BRCA1 and RRM1 Message RNA Level for Advanced NSCLC (BRAVO Study)
09:30 - 09:30 | Author(s): G. Gao
- Abstract
Loading... -
+
P3.01-061 - A Prognostic Model for Platinum-Doublet Regimens as Second-Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients
09:30 - 09:30 | Author(s): Y. Shi
- Abstract
Loading...
-
+
P3.03 - Poster Session/ Treatment of Locoregional Disease – NSCLC
- Type: Poster
- Track: Treatment of Locoregional Disease – NSCLC
- Presentations: 38
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.03-026 - Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer
09:30 - 09:30 | Author(s): H. Shuiyun
- Abstract
Loading...
